SCRI-huCAR19v2
/ Seattle Children's Hospital
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
June 26, 2024
CD19-specific CAR T Cells With a Fully Human Binding Domain for CD19+ Leukemia or Lymphoma
(clinicaltrials.gov)
- P1 | N=16 | Active, not recruiting | Sponsor: Seattle Children's Hospital | Phase classification: P1/2 ➔ P1
CAR T-Cell Therapy • Phase classification • Hematological Malignancies • Leukemia • Lymphoma • Oncology • Pediatrics
1 to 1
Of
1
Go to page
1